MicroRNAs: Key Regulators of Oncogenesis
Aberrant expression and function of microRNAs (miRNAs) in cancer have added a new layer of complexity to the understanding of development and progression of the disease state. It has been demonstrated that miRNAs play a momentous role in oncogenesis via regulating cell proliferation and apoptosis as...
Gespeichert in:
Format: | Elektronisch E-Book |
---|---|
Sprache: | English |
Veröffentlicht: |
Cham [u.a.]
Springer
2014
|
Schlagworte: | |
Online-Zugang: | TUM01 UBT01 Volltext |
Zusammenfassung: | Aberrant expression and function of microRNAs (miRNAs) in cancer have added a new layer of complexity to the understanding of development and progression of the disease state. It has been demonstrated that miRNAs play a momentous role in oncogenesis via regulating cell proliferation and apoptosis as oncogenes or tumour suppressors. Expression signatures of miRNAs offer exciting opportunities for crafting cutting edge strategies in the diagnosis, prognosis, and therapy of cancer. Since miRNAs can function as either oncogenes or tumor suppressor genes in the tortuous route of oncogenesis, the promise represented by using these small RNAs as therapeutic targets presents new perspectives to the landscape of cancer therapy by either inhibiting or augmenting their activity. This book devotes efforts to provide a broad framework for obtaining an in depth understanding of the state-of-the-art knowledge on abnormalities of miRNAs found to be associated with cancer pathogenesis and possible mechanisms underlying the substantial roles played by miRNAs in cancer development and progression. Also, it intends to pave the way for readers to gain novel insights into using miRNAs as cancer biomarkers and therapeutic platforms |
Beschreibung: | 1 Online-Ressource |
ISBN: | 9783319037257 |
DOI: | 10.1007/978-3-319-03725-7 |
Internformat
MARC
LEADER | 00000nmm a2200000 c 4500 | ||
---|---|---|---|
001 | BV041734980 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 140313s2014 |||| o||u| ||||||eng d | ||
020 | |a 9783319037257 |c Online |9 978-3-319-03725-7 | ||
024 | 7 | |a 10.1007/978-3-319-03725-7 |2 doi | |
035 | |a (OCoLC)871638028 | ||
035 | |a (DE-599)GBV779688821 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-703 |a DE-91 | ||
050 | 0 | |a RC261-271 | |
082 | 0 | |a 614.5999 | |
084 | |a WD 5355 |0 (DE-625)148201: |2 rvk | ||
084 | |a XH 1800 |0 (DE-625)152873:12905 |2 rvk | ||
084 | |a BIO 000 |2 stub | ||
245 | 1 | 0 | |a MicroRNAs |b Key Regulators of Oncogenesis |c Sadegh Babashah, ed. |
264 | 1 | |a Cham [u.a.] |b Springer |c 2014 | |
300 | |a 1 Online-Ressource | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
520 | 1 | |a Aberrant expression and function of microRNAs (miRNAs) in cancer have added a new layer of complexity to the understanding of development and progression of the disease state. It has been demonstrated that miRNAs play a momentous role in oncogenesis via regulating cell proliferation and apoptosis as oncogenes or tumour suppressors. Expression signatures of miRNAs offer exciting opportunities for crafting cutting edge strategies in the diagnosis, prognosis, and therapy of cancer. Since miRNAs can function as either oncogenes or tumor suppressor genes in the tortuous route of oncogenesis, the promise represented by using these small RNAs as therapeutic targets presents new perspectives to the landscape of cancer therapy by either inhibiting or augmenting their activity. This book devotes efforts to provide a broad framework for obtaining an in depth understanding of the state-of-the-art knowledge on abnormalities of miRNAs found to be associated with cancer pathogenesis and possible mechanisms underlying the substantial roles played by miRNAs in cancer development and progression. Also, it intends to pave the way for readers to gain novel insights into using miRNAs as cancer biomarkers and therapeutic platforms | |
650 | 4 | |a Medizin | |
650 | 4 | |a Medicine | |
650 | 4 | |a Oncology | |
650 | 4 | |a Human genetics | |
650 | 4 | |a Gene expression | |
650 | 4 | |a Medical genetics | |
650 | 4 | |a Drug interactions | |
650 | 0 | 7 | |a miRNS |0 (DE-588)7736808-3 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
689 | 0 | 1 | |a miRNS |0 (DE-588)7736808-3 |D s |
689 | 0 | |8 1\p |5 DE-604 | |
700 | 1 | |a Babashah, Sadegh |e Sonstige |4 oth | |
776 | 0 | 8 | |i Erscheint auch als |n Druckausgabe |z 978-3-319-03724-0 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-3-319-03725-7 |x Verlag |3 Volltext |
912 | |a ZDB-2-SBL | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-027181692 | ||
883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
966 | e | |u https://doi.org/10.1007/978-3-319-03725-7 |l TUM01 |p ZDB-2-SBL |x Verlag |3 Volltext | |
966 | e | |u https://doi.org/10.1007/978-3-319-03725-7 |l UBT01 |p ZDB-2-SBL |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804152020385398784 |
---|---|
any_adam_object | |
building | Verbundindex |
bvnumber | BV041734980 |
callnumber-first | R - Medicine |
callnumber-label | RC261-271 |
callnumber-raw | RC261-271 |
callnumber-search | RC261-271 |
callnumber-sort | RC 3261 3271 |
callnumber-subject | RC - Internal Medicine |
classification_rvk | WD 5355 XH 1800 |
classification_tum | BIO 000 |
collection | ZDB-2-SBL |
ctrlnum | (OCoLC)871638028 (DE-599)GBV779688821 |
dewey-full | 614.5999 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 614 - Forensic medicine; incidence of disease |
dewey-raw | 614.5999 |
dewey-search | 614.5999 |
dewey-sort | 3614.5999 |
dewey-tens | 610 - Medicine and health |
discipline | Biologie Medizin |
doi_str_mv | 10.1007/978-3-319-03725-7 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03103nmm a2200553 c 4500</leader><controlfield tag="001">BV041734980</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">140313s2014 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783319037257</subfield><subfield code="c">Online</subfield><subfield code="9">978-3-319-03725-7</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-319-03725-7</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)871638028</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBV779688821</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-703</subfield><subfield code="a">DE-91</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC261-271</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">614.5999</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WD 5355</subfield><subfield code="0">(DE-625)148201:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 1800</subfield><subfield code="0">(DE-625)152873:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIO 000</subfield><subfield code="2">stub</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">MicroRNAs</subfield><subfield code="b">Key Regulators of Oncogenesis</subfield><subfield code="c">Sadegh Babashah, ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cham [u.a.]</subfield><subfield code="b">Springer</subfield><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1="1" ind2=" "><subfield code="a">Aberrant expression and function of microRNAs (miRNAs) in cancer have added a new layer of complexity to the understanding of development and progression of the disease state. It has been demonstrated that miRNAs play a momentous role in oncogenesis via regulating cell proliferation and apoptosis as oncogenes or tumour suppressors. Expression signatures of miRNAs offer exciting opportunities for crafting cutting edge strategies in the diagnosis, prognosis, and therapy of cancer. Since miRNAs can function as either oncogenes or tumor suppressor genes in the tortuous route of oncogenesis, the promise represented by using these small RNAs as therapeutic targets presents new perspectives to the landscape of cancer therapy by either inhibiting or augmenting their activity. This book devotes efforts to provide a broad framework for obtaining an in depth understanding of the state-of-the-art knowledge on abnormalities of miRNAs found to be associated with cancer pathogenesis and possible mechanisms underlying the substantial roles played by miRNAs in cancer development and progression. Also, it intends to pave the way for readers to gain novel insights into using miRNAs as cancer biomarkers and therapeutic platforms</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Human genetics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gene expression</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical genetics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug interactions</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">miRNS</subfield><subfield code="0">(DE-588)7736808-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">miRNS</subfield><subfield code="0">(DE-588)7736808-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Babashah, Sadegh</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druckausgabe</subfield><subfield code="z">978-3-319-03724-0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-319-03725-7</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SBL</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-027181692</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-319-03725-7</subfield><subfield code="l">TUM01</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-319-03725-7</subfield><subfield code="l">UBT01</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV041734980 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T01:04:04Z |
institution | BVB |
isbn | 9783319037257 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-027181692 |
oclc_num | 871638028 |
open_access_boolean | |
owner | DE-703 DE-91 DE-BY-TUM |
owner_facet | DE-703 DE-91 DE-BY-TUM |
physical | 1 Online-Ressource |
psigel | ZDB-2-SBL |
publishDate | 2014 |
publishDateSearch | 2014 |
publishDateSort | 2014 |
publisher | Springer |
record_format | marc |
spelling | MicroRNAs Key Regulators of Oncogenesis Sadegh Babashah, ed. Cham [u.a.] Springer 2014 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Aberrant expression and function of microRNAs (miRNAs) in cancer have added a new layer of complexity to the understanding of development and progression of the disease state. It has been demonstrated that miRNAs play a momentous role in oncogenesis via regulating cell proliferation and apoptosis as oncogenes or tumour suppressors. Expression signatures of miRNAs offer exciting opportunities for crafting cutting edge strategies in the diagnosis, prognosis, and therapy of cancer. Since miRNAs can function as either oncogenes or tumor suppressor genes in the tortuous route of oncogenesis, the promise represented by using these small RNAs as therapeutic targets presents new perspectives to the landscape of cancer therapy by either inhibiting or augmenting their activity. This book devotes efforts to provide a broad framework for obtaining an in depth understanding of the state-of-the-art knowledge on abnormalities of miRNAs found to be associated with cancer pathogenesis and possible mechanisms underlying the substantial roles played by miRNAs in cancer development and progression. Also, it intends to pave the way for readers to gain novel insights into using miRNAs as cancer biomarkers and therapeutic platforms Medizin Medicine Oncology Human genetics Gene expression Medical genetics Drug interactions miRNS (DE-588)7736808-3 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 s miRNS (DE-588)7736808-3 s 1\p DE-604 Babashah, Sadegh Sonstige oth Erscheint auch als Druckausgabe 978-3-319-03724-0 https://doi.org/10.1007/978-3-319-03725-7 Verlag Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
spellingShingle | MicroRNAs Key Regulators of Oncogenesis Medizin Medicine Oncology Human genetics Gene expression Medical genetics Drug interactions miRNS (DE-588)7736808-3 gnd Krebs Medizin (DE-588)4073781-0 gnd |
subject_GND | (DE-588)7736808-3 (DE-588)4073781-0 |
title | MicroRNAs Key Regulators of Oncogenesis |
title_auth | MicroRNAs Key Regulators of Oncogenesis |
title_exact_search | MicroRNAs Key Regulators of Oncogenesis |
title_full | MicroRNAs Key Regulators of Oncogenesis Sadegh Babashah, ed. |
title_fullStr | MicroRNAs Key Regulators of Oncogenesis Sadegh Babashah, ed. |
title_full_unstemmed | MicroRNAs Key Regulators of Oncogenesis Sadegh Babashah, ed. |
title_short | MicroRNAs |
title_sort | micrornas key regulators of oncogenesis |
title_sub | Key Regulators of Oncogenesis |
topic | Medizin Medicine Oncology Human genetics Gene expression Medical genetics Drug interactions miRNS (DE-588)7736808-3 gnd Krebs Medizin (DE-588)4073781-0 gnd |
topic_facet | Medizin Medicine Oncology Human genetics Gene expression Medical genetics Drug interactions miRNS Krebs Medizin |
url | https://doi.org/10.1007/978-3-319-03725-7 |
work_keys_str_mv | AT babashahsadegh micrornaskeyregulatorsofoncogenesis |